SCHEMBL9700846

SCHEMBL9700846

O=C(CC1NCCc2c1[nH]c1ccccc21)NCCN1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 2/20 0.47
GRIN2B Q13224 1/20 0.47
STAT3 P40763 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPKAPK2 P49137 1/20 0.45
PARP1 P09874 1/20 0.44
POLB P06746 1/20 0.44
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCI P41743 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCZ Q05513 1/20 0.44
PRKCD Q05655 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9701609 0.99 KDM4E (0.48) KDM4EHSD17B10ALDH1A1LMNAGRIN2B
SCHEMBL2269874 0.80 GRIN2B (0.60) GRIN2BCYP3A4MAPKAPK2HTR7
SCHEMBL11366451 0.79 GRIN2B (0.65) GRIN2BCYP3A4MAPKAPK2HTR7
SCHEMBL3246180 0.74 GRIN2B (0.67) GRIN2BCYP3A4MAPKAPK2HTR7
SCHEMBL7894771 0.70 KDM4E (0.74) KDM4EHSD17B10ALDH1A1LMNAPARP1
SCHEMBL5532807 0.69 GRIN2B (0.70) GRIN2BCYP3A4MAPKAPK2HTR7
SCHEMBL8321835 0.69 KMT2A (0.70) KDM4EHSD17B10ALDH1A1GRIN2BCYP3A4
SCHEMBL10690885 0.68 LMNA (0.52) KDM4EALDH1A1LMNASTAT3MEN1
Hydrochloric Acid SCHEMBL11249624 0.68 KMT2A (0.72) KDM4EHSD17B10ALDH1A1GRIN2BCYP3A4
SCHEMBL13598000 0.68 KDM4E (0.88) KDM4EHSD17B10ALDH1A1LMNAPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992014465-A1 USE OF ANNULATED TETRAHYDROPYRIDINACETIC ACID DERIVATES FOR TREATING NEUROLOGICAL DISEASES BOEHRINGER INGELHEIM KG (DE) 1992-09-03 WO disclosed